Joint Action

David Hunter, PhD, FRACP (Rheum)

Joint Action is a podcast hosted by David Hunter. As a consequence of isolation, those living with osteoarthritis related disability may become less fit, more depressed and anxious, more socially isolated and gain weight. It is critical at times like this that people with osteoarthritis have their burden and disability minimised and their knowledge of how to manage the disease enhanced. Join David as he interviews the world's leading experts in osteoarthritis. Professor David Hunter is a rheumatology clinician researcher whose main research focus has been clinical and translational research in osteoarthritis. He is the Florance and Cope Chair of Rheumatology and Professor of Medicine at University of Sydney and the Royal North Shore Hospital, Sydney, Australia. He is ranked as the worlds leading expert in osteoarthritis on Expertscape.com since 2014. ​ You can send in your questions to hello@jointaction.info and follow David on Instagram at @ProfDavidHunter. To learn more about our research, visit our website at https://www.osteoarthritisresearch.com.au/ Hosted on Acast. See acast.com/privacy for more information.

  1. HÁ 3 DIAS

    Finding Responders: The Next Phase of OA Biomarkers with Dr Virginia Kraus, Dr Peter Mesenbrink, and Dr Jamie Collins

    Can identifying the right patients and the right endpoints transform how we test new osteoarthritis treatments? On this week's episode of Joint Action, we unpack what the FNIH Biomarkers Consortium has learned so far, and how their latest phase aims to deliver biomarkers that can make disease-modifying OA drug trials smaller, faster, and more likely to succeed. Dr. Virginia Byers Kraus is a Professor of Medicine, Pathology, and Orthopaedic Surgery at Duke University School of Medicine. A rheumatologist and translational scientist, her research focuses on osteoarthritis and biomarker development as part of the international FNIH Biomarkers Consortium. Peter G. Mesenbrink, Ph.D., is Executive Director of Biostatistics at Novartis and industry co-chair of the FNIH Biomarkers Consortium. With expertise in adaptive trial design, surrogate endpoint development, and data sharing policy, he is a frequent collaborator across industry, regulatory, and academic communities. Dr. Jamie Collins is a biostatistician at Brigham and Women's Hospital and Associate Professor of Orthopaedic Surgery at Harvard Medical School. As lead statistician for the FNIH OA Biomarkers Consortium, her research focuses on strengthening osteoarthritis clinical trials through innovative trial design and prognostic enrichment. RESOURCES FNIH: Treatment Response Biomarkers for Disease Modifying Osteoarthritis Drugs (DMOADs) CONNECT WITH US Naia Health: https://www.naiahealth.com.au/st-leonards-hubJoin one of our trials https://www.osteoarthritisresearch.com.au/current-trialsInstagram: @ProfDavidHunterTwitter: @ProfDavidHunter @jointactionorgEmail: hello@jointaction.infoWebsite: www.jointaction.info/podcast If you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.

    29 min
  2. 12 DE ABR.

    Defining the early-stage OA patient: the EsSKOA initiative with Dr Armaghan Mahmoudian

    What does it actually mean to have 'early-stage' osteoarthritis, and does catching it sooner really make a difference? On this week's episode of Joint Action, learn more about early-stage knee osteoarthritis, how it's defined, and why the EsSKOA initiative is changing the way we identify and understand the condition in its earliest phases. Dr. Armaghan Mahmoudian is an Assistant Professor of Movement Sciences and Health at the University of West Florida, where she teaches anatomy and physiology, biomechanics, and research methods, and co-directs the biomechanics and motor learning laboratory. As a clinician-scientist, her research focuses on understanding disease mechanisms and their impact on function and quality of life, with a particular interest in personalised medicine and disease prevention in an ageing population. RESOURCES EsSKOA InitiativeJournal article Reframing early-stage symptomatic knee osteoarthritis (EsSKOA): A strategic lens for trial design CONNECT WITH US Naia Health: https://www.naiahealth.com.au/st-leonards-hubJoin one of our trials https://www.osteoarthritisresearch.com.au/current-trialsInstagram: @ProfDavidHunterTwitter: @ProfDavidHunter @jointactionorgEmail: hello@jointaction.infoWebsite: www.jointaction.info/podcast If you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.

    39 min
  3. 29 DE MAR.

    The evidence behind knee bracing with Dr Melanie Holden

    On this week's episode of Joint Action, learn more about how knee braces work, who they help and how they can improve pain and function for people with knee osteoarthritis. Melanie Holden is a Chartered Physiotherapist and the Professor of Musculoskeletal Rehabilitation at the School of Medicine at Keele University. Her current research focuses on how to best manage musculoskeletal pain through rehabilitation using non-drug, non-surgical treatments. Her mission is to create high-quality, innovative research that improves patient care. She is an expert in a wide range of research methods, and she involves patients and the public at every stage of her research, to ensure that it reflects real-world needs and experiences. RESOURCES Journal article Provision of knee bracing for knee osteoarthritis (PROP OA): multicentre, parallel group, superiority, statistician blinded, randomised controlled trial CONNECT WITH US Naia Health: https://www.naiahealth.com.au/st-leonards-hubJoin one of our trials https://www.osteoarthritisresearch.com.au/current-trialsInstagram: @ProfDavidHunterTwitter: @ProfDavidHunter @jointactionorgEmail: hello@jointaction.infoWebsite: www.jointaction.info/podcast If you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.

    34 min
  4. 15 DE MAR.

    Counting the cost: osteoarthritis and workforce productivity with Dr Jason Jin and Prof Ilana Ackerman

    Knee osteoarthritis doesn’t just affect joints—it can limit people’s ability to participate fully in work and daily life, shaping their long‑term wellbeing and productivity. In this week's episode of Joint Action we are joined by Jason Jin and Ilana Ackerman to explore how knee osteoarthritis influences workforce participation. Dr Xingzhong (Jason) Jin is a conjoint research fellow at UNSW and the managing director of Precision Statistics Medtech Consulting. He is a musculoskeletal epidemiologist and health data scientist with a desire to bridge the gap between research and real-world healthcare impacts.   Professor Ilana Ackerman is a Research Professor at the School of Public Health and Preventive Medicine at Monash University and Deputy Director of the Musculoskeletal Health Unit. She is a musculoskeletal epidemiologist and an experienced orthopaedic physiotherapist and has led an important program of clinical and population-based research designed to quantify the personal and societal burden of hip and knee osteoarthritis, forecast trends in arthritis and joint replacement surgery, and evaluate the outcomes of joint replacement. She has also been involved in the development of multiple policy and guideline initiatives for osteoarthritis. RESOURCES Journal articles Loss of Productivity-Adjusted Life-Years in Working-Age Australians Due to Knee Osteoarthritis: A Life-Table Modeling Approach CONNECT WITH US Naia Health: https://www.naiahealth.com.au/st-leonards-hubJoin one of our trials https://www.osteoarthritisresearch.com.au/current-trialsInstagram: @ProfDavidHunterTwitter: @ProfDavidHunter @jointactionorgEmail: hello@jointaction.infoWebsite: www.jointaction.info/podcast If you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.

    36 min
  5. 15 DE FEV.

    Osteoarthritis research advances in 2025 with David Hunter and Anne-Marie Malfait

    Hear from the co-editors-in-chief of Osteoarthritis and Cartilage journal on what they thought were the latest advances in osteoarthritis research in 2025. Anne-Marie Malfait, MD, PhD, is Professor of Medicine and the Klaus E. Kuettner, Chair of Osteoarthritis Research at Rush University. She is co-Editor-in-Chief of Osteoarthritis and Cartilage journal alongside David Hunter. RESOURCES David's papers Comparative efficacy and safety of exercise modalities in knee osteoarthritis: systematic review and network meta-analysis Clinical and cost-effectiveness of a cycling and education intervention versus usual physiotherapy care for the treatment of hip osteoarthritis in the UK (CLEAT): a pragmatic, randomised, controlled trial The Cost-Effectiveness of Semaglutide and Tirzepatide for Patients With Knee Osteoarthritis and Obesity Anne-Marie's paper FM-dye inhibition of Piezo2 relieves mechanically evoked pain in mouse models of acute inflammatory and osteoarthritic knee painAssociation of Synovial Innate Immune Exhaustion With Worse Pain in Knee OsteoarthritisLipidomics unravels lipid changes in osteoarthritis articular cartilage CONNECT WITH US Join one of our trials https://www.osteoarthritisresearch.com.au/current-trialsInstagram: @ProfDavidHunterTwitter: @ProfDavidHunter @jointactionorgEmail: hello@jointaction.infoWebsite: www.jointaction.info/podcast If you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.

    39 min
4,9
de 5
24 avaliações

Sobre

Joint Action is a podcast hosted by David Hunter. As a consequence of isolation, those living with osteoarthritis related disability may become less fit, more depressed and anxious, more socially isolated and gain weight. It is critical at times like this that people with osteoarthritis have their burden and disability minimised and their knowledge of how to manage the disease enhanced. Join David as he interviews the world's leading experts in osteoarthritis. Professor David Hunter is a rheumatology clinician researcher whose main research focus has been clinical and translational research in osteoarthritis. He is the Florance and Cope Chair of Rheumatology and Professor of Medicine at University of Sydney and the Royal North Shore Hospital, Sydney, Australia. He is ranked as the worlds leading expert in osteoarthritis on Expertscape.com since 2014. ​ You can send in your questions to hello@jointaction.info and follow David on Instagram at @ProfDavidHunter. To learn more about our research, visit our website at https://www.osteoarthritisresearch.com.au/ Hosted on Acast. See acast.com/privacy for more information.

Você também pode gostar de